Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Business of developing engineered IgM antibodies for the treatment of cancer and autoimmune and516K100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States2.13M100.00%